Industry NewsNew data for Roche’s OCREVUS reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis
Industry NewsSolid form screening and selection: Why chemistry-led design brings the greatest value to pharmaceutical development
Product NewsSingle-cell multi-omics confirms high levels of CAR expression and low immunogenic profile of a novel CAR-T product